| mRNA |
PLX4720 |
CCLE |
pan-cancer |
AAC |
0.22 |
2e-05 |
| mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-05 |
| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
0.0001 |
| mRNA |
darinaparsin |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
0.0002 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.0003 |
| mRNA |
OSI-906 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0004 |
| mRNA |
PLX4720 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0005 |
| mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0005 |
| mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0007 |
| mRNA |
DMOG |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.0008 |